DCM
KITE

Dupont Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Dupont Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,600
Closed -$2.63M – 1040
2017
Q3 		$2.63M Buy
14,600
+7,113
+95% +$991K 0.06% 295
2017
Q2 		$776K Buy
7,487
+1,880
+34% +$153K 0.02% 579
2017
Q1 		$440K Sell
5,607
-5,101
-48% -$315K 0.01% 726
2016
Q4 		$480K Buy
+10,708
New +$525K 0.01% 692

Dupont Capital Management's KITE Position: Q4 2017 in Review

Dupont Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 14,600 shares — an estimated $2.63M sold.

Dupont Capital Management first reported a position in KITE in Q4 2016 and held it in 4 quarters. The position peaked at $2.63M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Dupont Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Dupont Capital Management sold 14,600 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.63M.
  • Dupont Capital Management first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 4 quarters.
  • Dupont Capital Management's Kite Pharma, Inc. position peaked at $2.63M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Dupont Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.